NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









TME Therapeutics Inc.

TME Therapeutics Inc.

Private
TokyoHealthcare & Life Scienceshttps://tme-tx.com/

Last Round

Grant

Jul 1, 2025

Total Funding Raised

$223,000

Company Overview

TME Therapeutics Inc. is a biotechnology company that develops novel therapeutics for the treatment of cancer and fibrosis by regulating the tumor microenvironment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

tumor microenvironmentTMERNA oligonucleotidesiRNA therapeuticpancreatic cancerCHST15stroma-modifying agentbiotech drug discoveryclinical-stage biotechcancer immunotherapyfibrosis treatmentdrug development pipelinebiopharma licensingRNA medicinesolid tumor therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TME Therapeutics Inc. Comparables

Compare TME Therapeutics Inc. with similar companies based on industry and business-model similarity.

TME Therapeutics Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

TME Therapeutics Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 1, 2025
GrantNov 17, 2022

TME Therapeutics Inc. Investors

Notable investors and investment history

TME Therapeutics Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TME Therapeutics Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TME Therapeutics Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Year Founded2018
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.